Ependymoma‐like tumor with mesenchymal differentiation harboring <i>C11orf95</i>‐<i>NCOA1</i>/<i>2</i> or ‐<i>RELA</i> fusion: A hitherto unclassified tumor related to ependymoma
Ran Tomomasa(Gunma University), Sumihito Nobusawa(Gunma University), Masahiko Nishiyama(Hiroshima University), Takashi Yao(Juntendo University), Satoshi Nakata(Gunma University), Yasuhito Arai, Kazuki Nabeshima(Fukuoka Tokushukai Hospital), Jun Takahashi, Junko Hirato(Gunma Children's Medical Center), Naoki Okura(International University of Health and Welfare), Atsushi Sasaki(Saitama Medical University), Reika Kawabata‐Iwakawa(Gunma University), Tatsuhiro Shibata(The University of Tokyo), Shinya Tanaka(Hokkaido University), Akihide Kondo(Juntendo University), Yoshiko Nakano, Yukitomo Ishi(Northwestern University), Mitsutaka Shiota(Kitano Hospital), Takanori Hirose(Saitama Medical University), Atsushi Natsume(Nagoya Future Culture College), Kohei Fukuoka(Hospital for Sick Children), Hideaki Yokoo(Gunma University), Koichi Ichimura(Hiroshima City Asa Citizens Hospital), Michihiro Kurimoto(Nagoya University), Tooru Inoue(National Kyushu Medical Center), Mikiko Aoki(Fukuoka University), Toshiyuki Enomoto(Toho University), Nozomi Suzuki(Japanese Red Cross Hokkaido College of Nursing), Yoshiaki Yuba(Kitano Hospital), Natsuko Hama, Junya Fujimura(Kagawa Prefectural Central Hospital), Yoshiki Shiba(Nagoya University)
Cited by 64
Related Papers
Pan-cancer analysis of whole genomes
|Nature|2020|3.3k
Metagenomic and metabolomic analyses reveal distinct stage-specific phenotypes of the gut microbiota in colorectal cancer
|Nature Medicine|2019|1.5k
Meta-analysis of fecal metagenomes reveals global microbial signatures that are specific for colorectal cancer
|Nature Medicine|2019|1.4k
Nrf2 Redirects Glucose and Glutamine into Anabolic Pathways in Metabolic Reprogramming
|Cancer Cell|2012|1.4k